Abstract
We investigated intravitreal triamcinolone acetonide injection for the treatment of macular edema due to central retinal vein occlusion in 20 patients. Mean central macular thickness at 3 days, 1, 3, 6, 12, 18, and 24 months postoperatively was different than baseline. Visual acuity did not change. Intravitreal triamcinolone injection significantly improves short-term anatomy, but recurrences and steroid-related complications were noted in the longer term.
Similar content being viewed by others
References
The Central Vein Occlusion Study Group. Evaluation of grid pattern photocoagulation for macular edema in central vein occlusion: the Central Vein Occlusion Study Group M Report. Ophthalmology 1995;102:1425–1433
Elman MJ, Raden RZ, Carrigan A. Intravitreal injection of tissue plasminogen activator for central retinal vein occlusion. Trans Am Ophthalmol Soc 2001;99:219–221
Opremcak EM, Bruce RA, Lomeo M, et al. Radial optic neurotomy for central retinal vein occlusion. Retina 2001;21:408–415
Weiss JN, Bynoe LA. Injection of tissue plasminogen activator into a branch retinal vein in eyes with central retinal vein occlusion. Ophthalmology 2001;108:2249–2257
McAllister IL, Douglas JP, Constable IJ, et al. Laser-induced chorioretinal venous anastomosis for nonischemic central retinal vein occlusion. Am J Ophthalmol 1998;126:219–229
Greenberg PB, Martidis A, Rogers AH, et al. Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion. Br J Ophthalmol 2002;86:247–248
Jonas JB, Hayler JK, Söfker A, et al. Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative diabetic retinopathy. Am J Ophthalmol 2001;131:468–471
Machemer R, Sugita G, Tano Y. Treatment of intraocular proliferations with intravitreal steroids. Trans Am Ophthalmol Soc 1979;77:171–180
Park CH, Jaffe GJ, Fekrat S. Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion. Am J Ophthalmol 2003;136:419–425
Bashshur ZF, Ma’luf RN, Allam S, et al. Intravitreal triamcinolone for the management of macular edema due to nonischemic central retinal vein occlusion. Arch Ophthalmol 2004;122:1137–1140
Krepler K, Ergun E, Sacu S, et al. Intravitreal triamcinolone acetonide in patients with macular oedema due to central retinal vein occlusion. Acta Ophthalmol Scand 2005;83:71–75
Sidney S, Castellan J. Nonparametric Statistics for the Behavioral Sciences. NewYork: McGraw-Hill, 1988, Ch 7, pp. 174–183
Nauck M, Karakiulais G, Perruchoud AP, et al. Corticosteroids inhibit the expression of the vascular endothelial growth factor gene in human vascular smooth muscle cells. Eur J Pharmacol 1998;341:309–315
Nauck M, Roth M, Tamm M, et al. Induction of vascular endothelial growth factor by platelet-activating factor and platelet-derived growth-factor is downregulated by corticosteroids. Am J Respir Cell Mol Biol 1997;16:398–406
Danis RP, Ciulla TA, Pratt LM, et al. Intravitreal triamcinolone acetonide in exudative age-related macular degeneration. Retina 2000;20:244–250
Jonas JB, Kreissig I, Degenring RF. Intravitreal triamcinolone acetonide as treatment of macular edema in central retinal vein occlusion. Graefe’s Arch Clin Exp Ophthalmol 2002;240:782–783
Ip M, Kumar KS. Intravitreal triamcinolone acetonide as treatment for macular edema from central retinal vein occlusion. Arch Ophthalmol 2002;120:1217–1219
Ip MS, Gottlieb JL, Kahana A, et al. Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion. Arch Ophthalmol 2004;122:1131–1136
Ip M, Kahana A, Altaweel M. Treatment of central vein occlusion with triamcinolone acetonide: an optical coherence tomography study. Semin Ophthalmol 2003;18:67–73
Martidis A, Duker JS, Greenberg PB, et al. Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology 2002;109:920–927
Antcliff RJ, Spalton DJ, Stanford MR, et al. Uveitic cystoid macular edema: an optical coherence tomography study. Ophthalmology 2001;108:765–772
Jonas JB, Kreissig I, Degenring RF. Intraocular pressure after intravitreal injection of triamcinolone acetonide. Br J Ophthalmol 2003;87:24–27
Kaushik S, Gupta V, Gupta A, et al. Intractable glaucoma following intravitreal triamcinolone in central retinal vein occlusion. Am J Ophthalmol 2004;137:758–760
Krepler K, Ergun E, Sacu S, et al. Intravitreal triamcinolone acetonide in patients with macular edema due to central retinal vein occlusion. Acta Ophthalmol Scand 2005;83:71–75
Author information
Authors and Affiliations
Corresponding author
Additional information
Drs. Batioglu, Özmert and Akmese are from the Department of Ophthalmology, Ankara University Faculty of Medicine, Ankara, Turkey.
The authors have stated that they do not have a significant financial interest or other relationship with any product manufacturer or provider of services discussed in this article. The authors do not discuss the use of off-label products, which includes unlabeled, unapproved, or investigative products or devices.
The authors treated macular edema due to central retinal vein occlusion with intravitreal triamcinolone injection. Therapy improved anatomy in the short term, but recurrences and steroid-related complications were noted in the longer term.
Rights and permissions
About this article
Cite this article
Batioglu, F., Özmert, E. & Akmese, E. Two-Year Results of Intravitreal Triamcinolone Acetonide Injection for the Treatment of Macular Edema Due to Central Retinal Vein Occlusion. Ann Ophthalmol 39, 307–312 (2007). https://doi.org/10.1007/s12009-007-9016-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12009-007-9016-x